Ta-Ken Biomedical Announces Adjustment to Cash Dividend and Capital Reserve Cash Payout Rate

1. Date of Board or Shareholders' Meeting Resolution: NA

2. Original Dividend Type and Amount: Q1 115 Cash Dividend: Total amount of NT$93,919,552, with a payout of NT$0.1159466 per share.

3. Revised Dividend Type and Amount: Q1 115 Cash Dividend: Total amount of NT$93,919,552, with a revised payout of NT$0.11658854 per share.

4. Reason for Change: Due to the company's repurchase of 4,460,000 treasury shares, the number of outstanding shares eligible for distribution has changed to 805,564,170 shares, necessitating an adjustment to the shareholder dividend rate.

5. Other Matters to be Disclosed: According to the board resolution dated May 7, 115, the chairman has been authorized to adjust the dividend payout rate.